Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 41 Ovarian Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Squamous Cell Carcinoma of Head and Neck 3 Lymphoma 3 Breast Diseases 3 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasms by Site 2 Medulloblastoma 2 Lymphoma, Mantle-Cell 2 Liposarcoma 2 Hematologic Neoplasms 2 Glioma 2 Carcinoma, Renal Cell 2 Breast Neoplasm Female 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Venous Thromboembolism 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Thyroid Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Cancer Recurrent × palbociclib × Clear all

NCT03820830 2026-04-09

POLAR

ETOP IBCSG Partners Foundation

Phase 3 Active not recruiting

Breast Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡